- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Top Stock Picks from Analysts
U.S. Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
504
0 new
Companies which are more than 50% undervalued based on analyst price target.
504 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MRNA | US$43.47 | -18.4% | -41.3% | US$16.5b | US$85.05 | PS3.3x | E18.4% | n/a | ||
SMMT | US$20.76 | 1.8% | 953.8% | US$16.1b | US$34.70 | PB35x | S85.4% | n/a | ||
RPRX | US$26.00 | -5.6% | -5.5% | US$15.5b | US$41.43 | PE10.1x | E3.2% | 3.2% | ||
PCVX | US$99.38 | -7.6% | 100.6% | US$12.9b | US$151.75 | PB3.6x | E-4.5% | n/a | ||
SRPT | US$114.32 | -8.6% | 38.6% | US$11.3b | US$189.86 | PE89.6x | E42.6% | n/a | ||
ASND | US$127.67 | -1.3% | 37.3% | US$7.6b | US$193.85 | PS22.6x | E68.6% | n/a | ||
LEGN | US$40.18 | -10.0% | -37.7% | US$7.4b | US$82.55 | PS16.2x | E64.7% | n/a | ||
VKTX | US$60.60 | -6.2% | 442.5% | US$7.0b | US$112.85 | PB7.4x | E2.9% | n/a | ||
IONS | US$37.77 | -2.7% | -23.2% | US$6.1b | US$61.56 | PS7.4x | E32.3% | n/a | ||
BBIO | US$24.62 | -3.5% | -16.5% | US$4.9b | US$46.98 | PS21.1x | E39.1% | n/a | ||
CRSP | US$50.73 | 0.7% | -8.3% | US$4.7b | US$81.54 | PS21.3x | E34.5% | n/a | ||
RARE | US$47.84 | -8.3% | 24.9% | US$4.7b | US$92.57 | PS8.4x | E54.3% | n/a | ||
IMVT | US$29.27 | -3.5% | -16.3% | US$4.6b | US$48.93 | PB9.6x | E8.3% | n/a | ||
IBRX | US$4.95 | -9.0% | 36.4% | US$3.8b | US$14.25 | PS2636x | E62.7% | n/a | ||
APLS | US$29.26 | 4.2% | -39.2% | US$3.7b | US$46.79 | PS5.1x | E72.2% | n/a | ||
MRUS | US$51.63 | -0.2% | 113.8% | US$3.6b | US$86.62 | PS98.4x | E19.3% | n/a | ||
APGE | US$57.35 | -1.6% | 235.2% | US$3.5b | US$88.67 | PB4.3x | E-28.2% | n/a | ||
IOVA | US$9.69 | -16.9% | 105.7% | US$3.2b | US$23.77 | PS32.5x | E63.3% | n/a | ||
FOLD | US$10.49 | -10.6% | -2.6% | US$3.2b | US$17.75 | PS6.3x | E66.6% | n/a | ||
ZLAB | US$28.96 | -6.3% | 2.2% | US$3.1b | US$52.27 | PS8.8x | E65.1% | n/a | ||
DYN | US$29.33 | 2.5% | 183.4% | US$2.8b | US$52.20 | PB3.8x | E12.7% | n/a | ||
IDYA | US$30.98 | 4.7% | 4.0% | US$2.8b | US$55.14 | PS682.7x | E9.1% | n/a | ||
ARWR | US$21.51 | 4.6% | -21.5% | US$2.7b | US$47.29 | PS136.1x | E28.2% | n/a | ||
CGON | US$36.98 | 0.1% | n/a | US$2.7b | US$66.75 | PS4602.1x | E-0.4% | n/a |